Filing Details
- Accession Number:
- 0001415889-23-002605
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-15 16:30:42
- Reporting Period:
- 2023-02-13
- Accepted Time:
- 2023-02-15 16:30:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-02-13 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-02-13 | 1,982 | $253.63 | 6,148 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-02-13 | 3,327 | $254.71 | 2,821 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-02-13 | 2,543 | $255.62 | 278 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-02-13 | 148 | $256.19 | 130 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-02-14 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-02-14 | 3,637 | $253.39 | 4,493 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-02-14 | 2,289 | $254.09 | 2,204 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-02-14 | 369 | $255.08 | 1,835 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-02-14 | 313 | $255.99 | 1,522 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-02-14 | 759 | $257.41 | 763 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-02-14 | 633 | $258.46 | 130 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2023-02-13 | 8,000 | $0.00 | 8,000 | $113.08 |
Common Stock | Stock Options | Disposition | 2023-02-14 | 8,000 | $0.00 | 8,000 | $113.08 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
432,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
424,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 166 | Indirect | By Spouse |
Common Stock | 644,183 | Indirect | By Trusts |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.
- This transaction was executed in multiple trades at prices ranging from $253.13 to $254.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $254.15 to $255.145. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $255.16 to $256.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $252.86 to $253.835. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $253.90 to $254.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $254.915 to $255.375. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $255.955 to $256.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $256.96 to $257.905. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $257.99 to $258.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.